6:12 PM
 | 
Mar 04, 2013
 |  BC Extra  |  Company News

Japan approves another biosimilar G-CSF

Nippon Kayaku Co. Ltd. (Tokyo:4272) said Japan approved Filgrastim NK, a biosimilar of granulocyte colony-stimulating factor (G-CSF),...

Read the full 76 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >